Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Cancer Therapy

Only individualized nutrition therapy helps prevent malnutrition

    • Nutrition
    • Oncology
    • RX
  • 2 minute read

Low-germ diets in the treatment of cancer patients are associated with significant risks from a scientific perspective and should no longer be practiced.

This urgent recommendation of the working group prevention and integrative oncology (PRIO) in the German cancer society, the working group nutrition in the German society for hematology and medical oncology, the German society for nourishing medicine, the federation of the Diätassistenten – German Federal association registered association (VDD) and the professional association Oecotrophologie registered association points to a substantial wrong supply with patients with cancer. Instead, the organizations call for individualized nutrition therapy to prevent malnutrition.

For a long time, it was considered standard practice for oncology patients undergoing intensive chemotherapy and/or stem cell therapy to follow a so-called “low-germ diet,” in which food choices are severely limited and, for example, fresh fruits and vegetables and unheated foods and spices are taboo. In a recent evidence-based statement, the organizations now point out the scientific facts: There are significantly more risks than benefits for patients associated with the germ-free (KE) diet that has been implemented to date. The cooperation partners and signatories of the statement also include the Working Group on Prevention and Integrative Oncology (PRIO) in the German Cancer Society.

Accordingly, the evidence base does not suggest that the incidence of infection from KE is lower than from a normal diet. On the contrary, various meta-analyses even show an increased susceptibility to infection when adhering to a KE. The main problem is the high risk of malnutrition with this type of diet. Since 2021, the Robert Koch Institute explicitly advises against a low-germ diet for immunocompromised patients, but points out compliance with kitchen hygiene in the handling and processing of food and provides orienting advice on avoiding food-associated diseases (e.g., only thoroughly cooked meat, at least pasteurized dairy products).

In their statement, the undersigned professional societies and working groups therefore call for comprehensive nutritional medical advice for patients undergoing and after intensive chemotherapy. Any weight loss would have to be countered by appropriate nutritional measures. The first priority is qualified nutritional counseling with patient training in kitchen hygiene.

 

Original publication:

www.ernaehrungs-umschau.de/print-artikel/14-03-2022-keimarme-ernaehrung-bei-der-hochdosistherapie-ein-risiko-fuer-patientinnen/

Previous Article
  • Locally advanced/metastatic breast carcinoma

44th San Antonio Breast Cancer Symposium: Best Of

  • Congress Reports
  • Gynecology
  • Oncology
  • RX
  • Studies
View Post
Next Article
  • Non-small cell lung cancer

Who benefits from targeted therapy?

  • Oncology
  • Pneumology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 5 min
  • Case study

Orofacial Manifestations of Phelan-McDermid Syndrome

    • RX
    • Cases
    • Education
    • General Internal Medicine
    • Genetics
    • Pediatrics
View Post
  • 3 min
  • Atherosclerotic Coronary Plaques in High-Risk Patients

Who benefits from preventive PCI?

    • RX
    • Cardiology
    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Studies
View Post
  • 5 min
  • Colorectal Cancer

Insulin Resistance, Obesity, and Progression

    • RX
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Oncology
View Post
  • 8 min
  • Modern asthma therapies

New data on biologics and triple therapy

    • RX
    • Congress Reports
    • General Internal Medicine
    • Pneumology
    • Studies
View Post
  • 4 min
  • From symptom to diagnosis

Abdominal Pain – Focal Nodular Hyperplasia

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Oncology
    • Radiology
View Post
  • 5 min
  • Clinically Suspected Arthralgias

“Watchful waiting” or intervention?

    • RX
    • Congress Reports
    • General Internal Medicine
    • Geriatrics
    • Rheumatology
    • Studies
View Post
  • 12 min
  • Hepatology and Metabolism

The Mediterranean Diet for MASLD/MASH—What the EASL-EASD-EASO Guidelines Specifically Recommend

    • RX
    • Cardiology
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • Prevention and health care
    • Studies
View Post
  • 5 min
  • Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?

Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs

    • RX
    • Congress Reports
    • General Internal Medicine
    • Nephrology
    • Rheumatology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.